Upperton Pharma Solutions, a UK-based CDMO, was awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored vaccines. Led by Professor Dame Sarah Gilbert at the University of Oxford’s Pandemic Sciences Institute, the project aims to address the limitations of intramuscular vaccine administration. By exploring oral delivery routes, the team seek...